1/3 Quality of Health Care Spotlight Series

Tuesday 8 March 2022, 12:00-13:00 CET

Health technology assessment (HTA) is a multidisciplinary process that summarizes comprehensive information about a health technology in a systematic, transparent, unbiased and robust manner. This information can encompass technical information and current use, safety and effectiveness, economics, as well as organizational, ethical, social and legal consequences.
HTA has the potential to contribute to quality of care by ensuring that safe and effective technologies are covered by statutory health systems. It can foster both the adoption of valuable innovation and the removal of obsolete technologies.
But how can HTA live up to its potential for improving the quality of care? What are the opportunities and challenges in developing HTA systems in Europe? What is the potential of cross-country collaboration in HTA? Join us to find out!

Keynote:
Reinhard Busse, TU Berlin

Speakers:
Rabia Kahveci, Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity
Elena Petelos, University of Crete & Maastricht University/ EUPHA
Rachel Kalf, Utrecht University
Matthias Perleth, German Federal Joint Committee

Moderators:
Dimitra Panteli & Erica Richardson, European Observatory on Health Systems and Policies
-----------------------------
This is one of the three webinars of the Quality of Health Care spotlight series.

This spotlight series consists of three webinars covering different quality strategies:
- health technology assessment (HTA);
- developing and implementing clinical guidelines; and
- using financial incentives in paying for quality (P4Q).

We investigate key policy questions associated with quality of care, bringing together evidence from research and country experiences. We review the potential challenges and opportunities of these quality strategies and consider how they are influenced by their unique settings.
We also explore the role of cross-country collaboration in HTA systems, the impact of COVID-19 on the development of clinical guidelines, and the effectiveness of P4Q programmes in health systems across Europe.

свернуть